Concord Drugs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 5, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	1,089	311	352	256	254	254
Market Cap Growth	247.90%	-11.63%	37.54%	0.84%	-0.17%	146.63%
Enterprise Value	1,277	501	521	428	362	351
Last Close Price	82.65	31.08	35.17	27.45	29.00	29.05
PE Ratio	181.82	92.45	74.47	25.95	15.91	7.74
PS Ratio	2.13	0.69	0.78	0.49	0.43	0.49
PB Ratio	3.16	0.91	1.04	0.81	0.89	0.95
P/TBV Ratio	3.16	0.91	1.04	0.81	0.89	0.95
P/FCF Ratio	-	22.37	-	31.71	-	-
P/OCF Ratio	-	8.35	44.39	15.38	32.75	1567937.89
EV/Sales Ratio	2.49	1.11	1.16	0.82	0.61	0.68
EV/EBITDA Ratio	31.75	12.12	12.88	9.36	6.37	10.63
EV/EBIT Ratio	47.56	18.54	20.93	14.52	9.24	18.11
EV/FCF Ratio	-	36.08	-	53.05	-	-
Debt / Equity Ratio	0.56	0.56	0.52	0.54	0.58	0.49
Debt / EBITDA Ratio	4.76	4.65	4.33	3.71	2.89	3.92
Debt / FCF Ratio	-	13.85	-	21.04	-	-
Net Debt / Equity Ratio	0.55	0.56	0.51	0.53	0.58	0.48
Net Debt / EBITDA Ratio	4.67	4.60	4.29	3.69	2.88	3.91
Net Debt / FCF Ratio	-	13.69	-76.85	20.91	-9.73	-3.52
Asset Turnover	-	0.73	0.77	0.91	1.11	0.95
Inventory Turnover	-	1.48	1.57	2.22	2.90	3.07
Quick Ratio	-	0.53	0.61	0.74	0.97	1.28
Current Ratio	-	1.56	1.79	2.01	1.77	2.22
Return on Equity (ROE)	-	0.99%	1.44%	3.28%	5.78%	13.06%
Return on Assets (ROA)	-	2.73%	2.66%	3.21%	4.60%	2.25%
Return on Invested Capital (ROIC)	3.64%	2.52%	3.75%	4.98%	6.58%	4.08%
Return on Capital Employed (ROCE)	-	6.90%	6.60%	8.00%	11.90%	5.80%
Earnings Yield	0.52%	1.08%	1.34%	3.85%	6.29%	12.92%
FCF Yield	-	4.47%	-0.64%	3.15%	-6.63%	-14.46%
Buyback Yield / Dilution	-25.47%	-	-7.35%	-6.53%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.